Thyme Care Secures $97M Series D Funding to Scale Value-Based Cancer Care
Thyme Care, the leading value-based cancer care enabler, has raised $97 million in Series D funding, further solidifying its position as a market leader in oncology care transformation. This round brings Thyme Care’s total capital raised to $275 million. The fundraise was led by existing investors CVS Health® Ventures, Foresite Capital, a16z Bio + Health, … Read more